Application Sponsors
ANDA 208535 | ZYDUS PHARMS USA INC | |
Marketing Status
None (Tentative Approval) | 001 |
Application Products
001 | TABLET;ORAL | 50MG/500MG;50MG/1000MG | 0 | METFORMIN HYDROCHLORIDE AND SITAGLIPTIN PHOSPHATE | METFORMIN HYDROCHLORIDE;SITAGLIPTIN PHOSPHATE |
FDA Submissions
UNKNOWN; | ORIG | 1 | TA | 2017-07-03 | STANDARD |
Submissions Property Types
CDER Filings
ZYDUS PHARMS USA INC
cder:Array
(
[0] => Array
(
[ApplNo] => 208535
[companyName] => ZYDUS PHARMS USA INC
[docInserts] => ["",""]
[products] => [{"drugName":"METFORMIN HYDROCHLORIDE AND SITAGLIPTIN PHOSPHATE","activeIngredients":"METFORMIN HYDROCHLORIDE;SITAGLIPTIN PHOSPHATE","strength":"50MG\/500MG;50MG\/1000MG","dosageForm":"TABLET;ORAL","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"07\/03\/2017","submission":"ORIG-1","actionType":"Tentative Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
[supplements] =>
[actionDate] => 2017-07-03
)
)